Dr Lal PathLabs shares plunged over 50% in early trade after the stock turned ex-bonus following a 1:1 bonus issue. The sharp fall is purely technical, reflecting price adjustment for additional shares, and does not impact investors’ overall holding value or ownership in the company.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets